In 2017, over 40 pharmaceutical ventures went public in China

On average, there were 4 IPO per month, and nearly 90 % of the companies had VC/PE support. The original investment period of 8-10 years was reduced to about 3-5 years. Total funds raised reached over 200 billion yuan. China Bio news release, November 30,...

China’s youngest academician, Tao XU (徐涛)

A biomedical engineer by education, Tao XU is presently Director of the Innovation Center of Instruments and Technologies for Life Sciences at CAS Beijing Institute of Life Sciences. His focus is on membrane and vesicle transport. Born in May 1970, he was a postdoc...